Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 6 | Future Journal of Pharmaceutical Sciences

Fig. 6

From: Sphaeranthus indicus Linn ameliorates streptozotocin-induced experimental diabetic neuropathy by targeting oxidative stress-mediated alterations

Fig. 6

Effect of MESIon diabetes-induced alterations in the reduced glutathione (GSH) level. Data are expressed as mean ± SEM (n = 6) and analyzed by one-way ANOVA followed by a post hoc Tukey's multiple range test. *P < 0.05, **P < 0.01 for MESI, and ***P < 0.001 for metformin-treated groups compared to the diabetic (STZ) control group. ###P < 0.001 for the diabetic (STZ) control group compared to the normal non-diabetic group. MESI (100), MESI (200), and MESI (400): Methanolic extract of Sphaeranthus indicus Linn (MESI) 100, 200, and 400 mg/ kg, p.o. treated rats

Back to article page